Sibanye Stillwater Limited ADR's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Sibanye Stillwater Limited ADR reported revenue of $129.7B (+15.6% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenue | $129.7B | $112.1B | $113.7B | $138.3B |
| Cost of sales | ($97.8B) | ($105.2B) | ($99.8B) | ($101.6B) |
| Interest income | $1.6B | $1.3B | $1.4B | $1.2B |
| Finance expense | ($5.0B) | ($4.6B) | ($3.3B) | ($2.8B) |
| Share-based payment expenses | ($2.1B) | ($251.0M) | ($113.0M) | ($218.0M) |
| (Loss)/gain on financial instruments | ($3.8B) | $5.4B | $235.0M | ($4.3B) |
| Gain/(loss) on foreign exchange differences | $155.0M | ($215.0M) | $2.0B | $616.0M |
| Share of results of equity-accounted investees after tax | $337.0M | $212.0M | ($1.2B) | $1.3B |
| Other costs | ($4.8B) | ($4.7B) | ($5.9B) | ($3.7B) |
| Other income | $1.4B | $2.6B | $1.2B | $1.1B |
| (Loss)/gain on disposal of property, plant and equipment | ($14.0M) | $55.0M | $105.0M | $162.0M |
| Impairments and reversal of impairments | ($14.0B) | ($9.2B) | ($47.5B) | $6.0M |
| Gain on acquisition | $0 | $0 | $898.0M | — |
| Occupational healthcare (loss)/gain | ($49.0M) | $76.0M | $365.0M | $211.0M |
| Restructuring costs | ($247.0M) | ($550.0M) | ($515.0M) | ($363.0M) |
| Transaction and project costs | ($4.5B) | ($851.0M) | ($474.0M) | ($152.0M) |
| Profit/(loss) before royalties, carbon tax and tax | $734.0M | ($3.7B) | ($38.8B) | $29.7B |
| Royalties | ($1.1B) | ($543.0M) | ($1.1B) | ($1.8B) |
| Carbon tax | $0 | ($2.0M) | ($2.0M) | $10.0M |
| Loss before tax | ($411.0M) | ($4.2B) | ($39.8B) | $27.9B |
| Mining and income tax | ($4.3B) | ($1.5B) | $2.4B | ($8.9B) |
| Loss for the year | ($4.7B) | ($5.7B) | ($37.4B) | $19.0B |
| Owners of Sibanye-Stillwater | ($5.2B) | ($7.3B) | ($37.8B) | $18.4B |
| Non-controlling interests (NCI) | $432.0M | $1.6B | $342.0M | $584.0M |
| Basic earnings per share (in ZAR per share) | -$1.83 | -$2.58 | -$13.34 | $6.51 |
| Diluted earnings per share (in ZAR per share) | -$1.83 | -$2.58 | -$13.34 | $6.50 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Property, plant and equipment | $64.3B | $66.9B | $61.3B | $76.9B |
| Right-of-use assets | $532.0M | $156.0M | $560.0M | $279.0M |
| Goodwill and other intangibles | $2.0B | $2.1B | $502.0M | $8.3B |
| Equity-accounted investments | $6.6B | $7.3B | $7.1B | $8.5B |
| Other investments | $4.3B | $3.5B | $3.2B | $3.3B |
| Environmental rehabilitation obligation funds | $7.3B | $6.7B | $5.9B | $5.3B |
| Other receivables | $1.9B | $491.0M | $523.0M | $798.0M |
| Deferred tax assets | $2.1B | $2.5B | $1.9B | $2.4B |
| Non-current assets | $89.0B | $89.6B | $81.1B | $105.9B |
| Inventories | $31.5B | $25.5B | $26.4B | $26.4B |
| Trade and other receivables | $6.8B | $5.7B | $8.9B | $7.5B |
| Other receivables | $4.8B | $156.0M | $26.0M | $81.0M |
| Tax receivable | $438.0M | $863.0M | $973.0M | $723.0M |
| Cash and cash equivalents | $17.2B | $16.0B | $25.6B | $26.1B |
| Assets held for sale | $30.0M | $70.0M | $0 | $0 |
| Current assets | $60.8B | $48.4B | $61.8B | $60.8B |
| Total assets | $149.7B | $138.0B | $142.9B | $166.6B |
| Stated share capital | $21.6B | $21.6B | $21.6B | $21.6B |
| Other reserves | $37.0B | $36.1B | $35.6B | $32.7B |
| Accumulated loss | ($19.1B) | ($13.8B) | ($8.5B) | $33.8B |
| Equity attributable to owners of Sibanye-Stillwater | $39.5B | $44.0B | $48.7B | $88.1B |
| Non-controlling interests | $4.6B | $4.3B | $2.9B | $2.9B |
| Total equity | $44.2B | $48.3B | $51.6B | $91.0B |
| Borrowings and derivative financial instrument | $31.9B | $41.1B | $24.9B | — |
| Lease liabilities | $481.0M | $203.0M | $384.0M | $208.0M |
| Environmental rehabilitation obligation and other provisions | $14.1B | $11.9B | $12.5B | $8.6B |
| Occupational healthcare obligation | $211.0M | $334.0M | $400.0M | $781.0M |
| Cash-settled share-based payment obligations | $2.7B | $1.7B | $2.7B | $5.0B |
| Other payables | $1.4B | $1.8B | $3.4B | $2.5B |
| Deferred revenue | $14.2B | $7.0B | $6.3B | $6.4B |
| Tax, carbon tax and royalties payable | $14.0M | $13.0M | $64.0M | $11.0M |
| Deferred tax liabilities | $6.5B | $4.8B | $4.2B | $9.4B |
| Non-current liabilities | $71.4B | $68.8B | $54.9B | $55.4B |
| Borrowings and derivative financial instrument | $11.4B | $552.0M | $15.5B | — |
| Lease liabilities | $166.0M | $175.0M | $198.0M | $111.0M |
| Environmental rehabilitation obligation and other provisions | $161.0M | $327.0M | $832.0M | — |
| Occupational healthcare obligation | $173.0M | $2.0M | $0 | $44.0M |
| Cash-settled share-based payment obligations | $935.0M | $121.0M | $432.0M | $284.0M |
| Trade and other payables | $16.8B | $15.6B | $16.5B | $15.7B |
| Other payables | $2.3B | $1.6B | $2.0B | $3.9B |
| Deferred revenue | $1.2B | $1.7B | $305.0M | $21.0M |
| Tax, carbon tax and royalties payable | $602.0M | $329.0M | $679.0M | — |
| Liabilities associated with assets held for sale | $480.0M | $451.0M | — | — |
| Current liabilities | $34.2B | $20.9B | $36.4B | $20.2B |
| Total equity and liabilities | $149.7B | $138.0B | $142.9B | $166.6B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash generated by operations | $13.7B | $4.4B | — | — |
| Deferred revenue advance received | $10.7B | $3.3B | — | — |
| Cash-settled share-based payments paid | ($649.0M) | ($751.0M) | — | — |
| Payment of Marikana dividend obligation | $0 | ($38.0M) | — | — |
| Additional deferred/contingent payments relating to acquisition of a business | $0 | ($44.0M) | — | — |
| Change in working capital | $2.3B | $6.9B | — | — |
| Total cash generated by operations | $26.1B | $13.7B | — | — |
| Interest received | $849.0M | $882.0M | — | — |
| Interest paid | ($2.3B) | ($2.1B) | — | — |
| Royalties and carbon tax paid | ($1.3B) | ($784.0M) | — | — |
| Royalties and carbon tax refunded | $431.0M | — | — | — |
| Tax paid | ($2.5B) | ($1.5B) | — | — |
| Tax refunded | $489.0M | — | — | — |
| Dividends paid | ($302.0M) | ($173.0M) | — | — |
| Net cash from operating activities | $21.4B | $10.1B | — | — |
| Additions to property, plant and equipment | ($20.3B) | ($21.6B) | — | — |
| Proceeds on disposal of property, plant and equipment | $163.0M | $129.0M | — | — |
| Acquisition of subsidiaries, net of cash acquired | ($2.0B) | ($2.7B) | — | — |
| Dividends received | $418.0M | $402.0M | — | — |
| Additions to other investments | ($850.0M) | ($465.0M) | — | — |
| Disposals of other investments | $765.0M | $457.0M | — | — |
| Loans advanced to investee | $0 | ($26.0M) | — | — |
| Repayment of loan from investee | $21.0M | — | — | — |
| Proceeds on sale of assets held for sale | $318.0M | — | — | — |
| Acquisition of equity-accounted investment | ($91.0M) | ($35.0M) | — | — |
| Contributions to environmental rehabilitation funds | ($158.0M) | ($273.0M) | — | — |
| Payment of deferred/contingent payment | $0 | ($292.0M) | — | — |
| Proceeds from environmental rehabilitation funds | $19.0M | $24.0M | — | — |
| Net cash used in investing activities | ($21.7B) | ($24.3B) | — | — |
| Loans raised | $7.9B | $8.3B | — | — |
| Loans repaid | ($4.9B) | ($3.3B) | — | — |
| Lease payments | ($228.0M) | ($208.0M) | — | — |
| Acquisition of NCI | ($45.0M) | $0 | — | — |
| Proceeds from NCI on rights issue | $0 | $0 | — | — |
| Net cash from financing activities | $2.8B | $4.7B | — | — |
| Net increase/(decrease) in cash and cash equivalents | $2.5B | ($9.5B) | — | — |
| Effect of exchange rate fluctuations on cash held | ($1.3B) | ($21.0M) | — | — |
| Cash and cash equivalents at beginning of the year | $16.0B | $25.6B | — | — |
| Cash and cash equivalents at end of the year | $17.2B | $16.0B | $25.6B | $26.1B |
Sibanye Stillwater Limited ADR score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.